All AbMole products are for research use only, cannot be used for human consumption.
Tafenoquine is an antimalarial primaquine analog being investigated to treat and prevent Plasmodium vivax infections. It can eliminate both blood and liver stages of Plasmodium vivax. Tafenoquine has also been tested as a therapy for leishmaniasis.
| Molecular Weight | 581.58 |
| Formula | C24H28F3N3O3 · C4H6O4 |
| CAS Number | 106635-81-8 |
| Form | Solid |
| Solubility (25°C) | DMSO: 5 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[1] No authors listed. Tafenoquine
[2] No authors listed. Aust Prescr. Tafenoquine succinate for malaria prevention
[3] Cindy S Chu, et al. Tafenoquine and G6PD: a primer for clinicians
| Related Parasite Products |
|---|
| Nanaomycin A
Nanaomycin A is the first selective DNMT3B inhibitor with an IC50 of 500 nM. Nanaomycin A, a quinone antibiotics, reactivates silenced tumor suppressor genes in human cancer cells. Nanaomycin A inhibits in vitro growth of the human malaria parasite Plasmodium falciparum with an IC80 value of 33.1 nM. |
| Ivermectin B1a
Ivermectin B1a is a main component of Ivermectin. Ivermectin (MK-933) is a broad-spectrum anti-parasite agent. |
| Asparagusic acid
Asparagusic acid is a sulfur-containing flavor component produced by Asparagus officinalis Linn., with anti-parasitic effect. Asparagusic acid is also a plant growth inhibitor. |
| ML251
ML251, a potent nanomolar T. |
| AN3661
AN3661, a potent antimalarial lead compound, targets a Plasmodium falciparum cleavage and polyadenylation specificity factor homologue subunit 3 (PfCPSF3). |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
